Co-Diagnostics IncCODX
Price$1.08

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $721.4K-81.6% YoYTTM through 30 Jun 2026
Net Income -$47.1MTTM through 30 Jun 2026
Free Cash Flow -$27.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin64.3%
Operating Margin-8,058.8%
Net Margin-6,523.1%

Returns

-227.3%ROE
-189.5%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.87x
Net Debt-$11.9Mnet cash position
Cash & Equivalents$3.6M

Quality Metrics

Altman Z-Score-16.44
Piotroski F-Score1 / 9
FCF Margin-3,808.0%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $622.5K
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-35.25

Dividend

No dividend

Capital Allocation

Capex Intensity50.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.